Case-By-Case Guide As Justices Eye Landmark Pharma Law

Drugmakers and prominent allies are inundating the U.S. Supreme Court with calls to scrutinize Medicare’s new power to slash payments by tens of billions of dollars, and the justices look poised to take up or turn down a fistful of legal challenges in one fell swoop.

Continue reading →